EUVIMEDEUVIMED entdecken
Open Access

Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation

Grace A Osborne iD, Lin Zhang iD, Feiyang Ma iD, Mehrnaz Gharaee-Kermani iD, Jessica L Turnier iD, Amanda N Victory, Amy Hurst, Bin Xu iD, Elisabeth A Pedersen iD, Rachael Bogle iD, Celine C Berthier iD, Vladimir Ognenovski und 7 weitere

Science Translational Medicine · 24.12.2025 · 17 (830)

DOI: 10.1126/scitranslmed.aea9007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 24.12.2025. Verfasst von Grace A Osborne und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Dermatomyositis, Monocytes, Inflammation, Janus Kinase 1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dermatomyositis is a rare yet devastating autoimmune disease characterized by inflammatory and vasculopathic changes in skin and muscle. Dermatomyositis and systemic lupus erythematosus (lupus) skin lesions have overlapping clinical and histopathological features but show disparate responses to available therapeutics, with dermatomyositis skin disease often relapsing and being recalcitrant. To investigate dermatomyositis immunopathogenesis, nonlesional skin, lesional skin, and circulating immune cells from patients with dermatomyositis were analyzed using single-cell RNA sequencing. Samples were analyzed in parallel with lesional and nonlesional lupus skin, healthy control skin, and peripheral blood from all three patient groups. We demonstrate a pervasive type I interferon signature in dermatomyositis stroma that persisted in culture and was distinguished from lupus by up-regulation of vascular endothelial growth factor and interleukin-18 signaling in dermatomyositis keratinocytes. Furthermore, endothelial cells in lesional dermatomyositis exhibited decreased proliferation, which was not observed in lupus skin. Using cell communication networks, we identified a population of dermatomyositis-specific monocytes interacting with nonproliferating endothelial cells. Coculture of monocytes from patients with dermatomyositis with endothelial cells resulted in increased endothelial cell apoptosis, which was inhibited by Janus kinase 1 (JAK1) blockade. JAK1 inhibition also resulted in reversal of dermatomyositis stromal and inflammatory signatures. Together, our data provide a comprehensive cross-disease characterization of lesional and nonlesional skin in dermatomyositis and implicate monocyte-mediated endothelial cell dysfunction in dermatomyositis vasculopathy. Moreover, these results suggest that JAK inhibition may offer a suitable therapeutic intervention for refractory skin disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisMonocytesInflammationJanus Kinase 1Vascular DiseasesHumansEndothelial CellsSkinFemaleKeratinocytesApoptosisMaleLupus Erythematosus, SystemicSignal TransductionInterferon Type IAdultMiddle AgedCell Proliferation

Substanzen

Janus Kinase 1JAK1 protein, humanInterferon Type I

Autor:innen und Institutionen

  • Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
  • Division of Rheumatology, Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA.
  • Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

ORCID-Profile: Grace A Osborne, Lin Zhang, Feiyang Ma, Mehrnaz Gharaee-Kermani, Jessica L Turnier, Bin Xu, Elisabeth A Pedersen, Rachael Bogle, Celine C Berthier, Lam C Tsoi, Allison C Billi, Johann E Gudjonsson, Benjamin Klein, Pei-Suen Tsou, J Michelle Kahlenberg

Förderung

  • NIAID NIH HHS
  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • U-M Skin Biology and Diseases Resource Center
  • the Department of Defense
  • Leo Foundation

Zitieren

APA

Osborne, G. A., Zhang, L., Ma, F., Gharaee-Kermani, M., Turnier, J. L., Victory, A. N., Hurst, A., Xu, B., Pedersen, E. A., Bogle, R., Berthier, C. C., Ognenovski, V., Nakamura, M., Tsoi, L. C., Billi, A. C., Gudjonsson, J. E., Klein, B., Tsou, P. S., & Kahlenberg, J. M. (2025). Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation. Science Translational Medicine, 17(830). https://doi.org/10.1126/scitranslmed.aea9007

Vancouver

Osborne GA, Zhang L, Ma F, Gharaee-Kermani M, Turnier JL, Victory AN, et al. Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation. Science Translational Medicine. 2025;17(830). doi:10.1126/scitranslmed.aea9007

BibTeX
@article{Osborne2025,
  author = {Osborne, Grace A and Zhang, Lin and Ma, Feiyang and Gharaee-Kermani, Mehrnaz and Turnier, Jessica L and Victory, Amanda N and Hurst, Amy and Xu, Bin and Pedersen, Elisabeth A and Bogle, Rachael and Berthier, Celine C and Ognenovski, Vladimir and Nakamura, Mio and Tsoi, Lam C and Billi, Allison C and Gudjonsson, Johann E and Klein, Benjamin and Tsou, Pei-Suen and Kahlenberg, J Michelle},
  title = {Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {830},
  doi = {10.1126/scitranslmed.aea9007}
}
Kostenlos starten →